Zhang, L., Normant, E., Adam, A., Peluso, M. O., Armet, C. M., O’Connor, R. W., . . . Paterson, A. M. The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a. BMJ Publishing Group.
Chicago Style (17th ed.) CitationZhang, Li, et al. The Fully Human Anti-CD47 Antibody SRF231 Exerts Dual-mechanism Antitumor Activity via Engagement of the Activating Receptor CD32a. BMJ Publishing Group.
MLA (9th ed.) CitationZhang, Li, et al. The Fully Human Anti-CD47 Antibody SRF231 Exerts Dual-mechanism Antitumor Activity via Engagement of the Activating Receptor CD32a. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.